GSA Capital Partners’s Pliant Therapeutics PLRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$507K	Sell	402,092 -221,606	-36%	-$280K	0.03%	912
2025 Q4	$761K	Buy	623,698 +462,814	+288%	+$695K	0.07%	533
2025 Q3	$238K	Buy	160,884 +146,742	+1,038%	+$224K	0.02%	1338
2025 Q2	$16K	Sell	14,142 -20,530	-59%	-$29K	﹤0.01%	1693
2025 Q1	$47K	Buy	+34,672	New	+$210K	﹤0.01%	1551
2023 Q4	–	Sell	-45,587	Closed	-$790K	–	1823
2023 Q3	$790K	Buy	+45,587	New	+$790K	0.07%	525
2023 Q2	–	Sell	-19,206	Closed	-$511K	–	1849
2023 Q1	$511K	Sell	19,206 -1,053	-5%	-$30K	0.05%	706
2022 Q4	$392K	Sell	20,259 -1,976	-9%	-$41.3K	0.05%	756
2022 Q3	$464K	Sell	22,235 -50,818	-70%	-$972K	0.06%	626
2022 Q2	$585K	Buy	73,053 +4,817	+7%	+$30.8K	0.09%	399
2022 Q1	$478K	Buy	68,236 +9,643	+16%	+$98.4K	0.06%	559
2021 Q4	$791K	Buy	58,593 +32,726	+127%	+$520K	0.1%	320
2021 Q3	$437K	Buy	+25,867	New	+$549K	0.04%	779